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ABSTRACT The emergence of mobilized colistin resistance genes (mcr) has become a
serious concern in clinical practice, compromising treatment options for life-threatening
infections. In this study, colistin-resistant Klebsiella pneumoniae harboring mcr-8.1 was re-
covered from infected patients in the largest public hospital of Bangladesh, with a prev-
alence of 0.3% (3/1,097). We found mcr-8.1 in an identical highly stable multidrug-
resistant IncFIB(pQil) plasmid of !113 kb, which belonged to an epidemiologically
successful K. pneumoniae clone, ST15. The resistance mechanism was proven to be hori-
zontally transferable, which incurred a fitness cost to the host. The core genome phylog-
eny suggested the clonal spread of mcr-8.1 in a Bangladeshi hospital. Core genome
single-nucleotide polymorphisms among the mcr-8.1-positive K. pneumoniae isolates
ranged from 23 to 110. It has been hypothesized that mcr-8.1 was inserted into IncFIB-
(pQil) with preexisting resistance loci, blaTEM-1b and blaCTX-M-15, by IS903B. Coincidentally,
all resistance determinants in the plasmid [mcr-8.1, ampC, sul2, 1d-APH(6), APH(3==)-Ib,
blaTEM-1b, blaCTX-M-15] were bracketed by IS903B, demonstrating the possibility of intra-
and interspecies and intra- and intergenus transposition of entire resistance loci. This is
the first report of an mcr-like mechanism from human infections in Bangladesh. How-
ever, given the acquisition of mcr-8.1 by a sable conjugative plasmid in a successful
high-risk clone of K. pneumoniae ST15, there is a serious risk of dissemination of mcr-8.1
in Bangladesh from 2017 onwards.
IMPORTANCE There is a marked paucity in our understanding of the epidemiology of
colistin-resistant bacterial pathogens in South Asia. A report by Davies and Walsh (Lan-
cet Infect Dis 18:256–257, https://doi.org/10.1016/S1473-3099(18)30072-0, 2018) suggests
the export of colistin from China to India, Vietnam, and South Korea in 2016 was
approximately 1,000 tons and mainly used as a poultry feed additive. A few reports
forecast that the prevalence of mcr in humans and livestock will increase in South Asia.
Given the high prevalence of blaCTX-M-15 and blaNDM in India, Bangladesh, and Pakistan,
colistin has become the invariable option for the management of serious infections,
leading to the emergence of mcr-like mechanisms in South Asia. Systematic scrutiny of
the prevalence and transmission of mcr variants in South Asia is vital to understanding
the drivers of mcr genes and to initiate interventions to overcome colistin resistance.
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Klebsiella pneumoniae is an opportunistic Gram-negative pathogen that is mostlyassociated with nosocomial infections (1). Carbapenems have been widely used to
treat multidrug-resistant (MDR) K. pneumoniae infections, leading to the emergence of
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carbapenem resistance, where colistin is one of a few viable options (2, 3). The
prevalence of colistin resistance is rapidly expanding in South Asia (4–10). Colistin
resistance is either mediated by mutational disruption or insertional inactivation of
mgrB (11) or via the acquisition of MCR plasmid-mediated resistance (12, 13). Here, we
characterize a clinical epidemic K. pneumoniae clone harboring mcr-8.1 from a Bangla-
deshi hospital.
A pilot antimicrobial resistance (AMR) survey was conducted from 21 October 2016
to 23 September 2017 at Dhaka Medical College Hospital (DMCH), which included 1,097
culture-positive clinical specimens. The project was approved by the Ethical Review
Committee of DMCH (MEU-DMC/ECC/2017122). K. pneumoniae was recovered on chro-
mogenic UTI containing vancomycin (10 mg/liter) and identification by matrix-assisted
laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS; MALDI
Biotyper; Bruker Daltonics, Inc., Billerica, MA, USA). MICs of relevant antimicrobials were
determined by agar dilution and the MIC of colistin by broth microdilution. Suscepti-
bility patterns of antimicrobials were interpreted according to EUCAST breakpoints.
Sequencing was performed using Illumina MiSeq (Illumina Inc., San Diego, CA) and
Nanopore (Oxford Nanopore Technologies, Oxford, UK) platforms. We adopted a hybrid
strategy to assemble draft genomes using Unicycler (v0.4.0) (see Text S1 in the
supplemental material). Pangenome analysis was performed using Roary (v3.12.0). A
maximum likelihood phylogenetic tree was built using FastTree (v2.1.0) and visualized
using Phandango and iTOL (v5.3). Intraclade single-nucleotide polymorphisms (SNPs) were
identified using Snippy (v4.4.5). Plasmid size was confirmed by pulsed-field gel electropho-
resis (PFGE) of S1 nuclease DNA digests and mcr-8.1 probing. Conjugation assays were
performed using Escherichia coli J53 as the recipient (9). Serial passaging of MCR-positive K.
pneumoniae (MCRPKP) was performed in a colistin-free medium up to 12 days, and
genomic DNA (gDNA) was extracted on days 0, 3, 6, 9, and 12. Plasmid stability was
FIG 1 Phylogenetic tree of K. pneumoniae ST15 identified in this study (n" 29). Shown is a maximum likelihood (ML) phylogenetic tree constructed using a
pangenome alignment. Strains were grouped together based on the similarity of genes and the presence of genes in the accessory genome using Roary
(v3.12.0). Epidemiologically important resistance genes are indicated by orange cells, accessory genes by blue cells, and the absence of genes by white cells.
NICU, neonatal intensive care unit; ICU, intensive care unit.
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FIG 2 Genetic organization of plasmid harboring mcr-8.1. (A) Circular view of pKP914 (accession no. CP046952). (B) Schematic layout of
sequence comparison of pKP914 (accession no. CP046952) against FDAARGOS_440 plasmid unnamed2 (accession no. CP023922.1) and
(Continued on next page)
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assessed by relative abundance ofmcr-8.1 compared to that of housekeeping genes (HKGs)
using quantitative PCR (Bio-Rad, USA) (Text S2). The in vitro growth rate of E. coli J53 and
transconjugants (TDM697b, TDM782, and TDM914b) was determined by optical density
(OD) in 30-min intervals for 24 h using FLUOstar Omega (BMG Labtech Ltd., Aylesbury, UK).
The growth rate of each transconjugant was compared to that of E. coli J53 by unpaired
two-tailed t test using GraphPad Prism (v7.04) (Text S3).
Description of cases with infections by MCRPKP. In this study, 3 K. pneumoniae
isolates (3/1,097, 0.3%) were phenotypically resistant to colistin. MCRPKP isolates were
recovered from the urine of two patients admitted under urology and the blood of a
third patient in the neonatal intensive care unit (NICU). Case 1 (BD_DM_697) was a
55-year-old male with benign enlargement of the prostate with diabetes mellitus and
a history of catheterization for 13 days. Case 2 (BD_DM_782) was a 63-year-old male
patient with a left renal tumor, a history of catheterization for 15 days, and hematuria. These
patients were discharged on days 20 and 35 of hospitalization, respectively. Case 3
(BD_DM_914) was a 5-day preterm low-birth-weight neonate with late-onset neonatal
sepsis who died within 18 days after hospital admission. We did not observe any overlap-
ping of hospital stay among the MCRPKP cases. MCRPKP isolates were coresistant to
amoxicillin-clavulanate, piperacillin-tazobactam, cephalosporins (ceftazidime and cefo-
taxime), ciprofloxacin, levofloxacin, gentamicin, trimethoprim-sulfamethoxazole, and colis-
tin and susceptible to carbapenems, amikacin, fosfomycin, and tigecycline. Although
MCRPKP cases initially were shown to be treated with inappropriate antimicrobials, we have
no data on whether the antibiotic therapy was subsequently changed based on the
sensitivity report from the local laboratory.
Clonal spread of mcr-8.1. In silico genome-wide analysis of MCRPKP detected a
1,698-bp open reading frame (ORF), encoding a phosphoethanolamine transferase,
showing 100% nucleotide identity to mcr-8.1. The prevalence of K. pneumoniae among
all clinical isolates from this study was 21% (228/1097), of which 13% (29/228) belonged
to ST15. K. pneumoniae ST15 harboring mcr-8.1 was clustered in one clade (Fig. 1),
suggesting the clonal spread of MCRPKP. SNP mapping found 110 and 107 SNPs in
BD_DM_782 and BD_DM_914, respectively, compared to BD_DM_697, and 23 SNPs in
BD_DM_782 compared to BD_DM_914. MCR-8 was described previously in K. pneu-
moniae ST1, of human origin, and K. pneumoniae ST42, of animal origin (14). K.
pneumoniae ST15 has been regarded as a successful clone in disseminating blaCTX-M-15
globally (15). The draft genome sequences and S1 PFGE indicate that mcr-8.1 elements in
K. pneumoniae were located on identical IncFIB(pQil) plasmids of !113 kb (GenBank
accession no. CP046384, CP046952, and CP046942) (Fig. 2 and Fig. S1). The gene mcr-8.1
was stable after serial passaging without any antibiotic challenge. Compared to that at
day 0, the abundance of mcr-8.1 versus HKG was static up to day 12 (Fig. S2). Yang et
al. (16) reported that colistin susceptibility could be attenuated after serial passaging of
mcr-1-positive strains in antibiotic-free medium. Our findings demonstrate that the
IncFIB(pQil) plasmid harboring mcr-8.1 was remarkably stable, suggesting adaptive
plasmid-host evolution (17). K. pneumoniae ST15 can be a vector capable of spreading
mcr-mediated colistin resistance, particularly in a setting with suboptimal infection
control practices (18).
Genetic context and dynamics of plasmids harboring mcr-8.1. Genome-wide
analyses demonstrated that the plasmids recovered from the MCRPKP were almost
identical to each other (Fig. S3). Complete plasmid sequences were determined for
pKP782 (accession no. CP046384) and pKP914 (accession no. CP046952) by hybrid
assembly, while pKP697 (accession no. CP046942) was not successfully closed. One
pMR0617ctx (accession no. CP024040.1). Arrows represent the position and transcriptional direction of the open reading frames. Genomic
comparison was performed by Artemis Comparison Tool (ACT) (v.18.0.1). (C) Comparison of genetic environments of mcr-8.1. APH,
aminoglycoside phosphotransferase; baeS, histidine-protein kinase; bla, beta-lactamase; Cob, cobalamin biosynthesis; Cop, copper homeo-
stasis transcription factor; dgkA, diacylglycerol kinase; DJ-1/PfpI, cysteine peptidase; gtf, glucosyltransferase; Hha, hemolysin expression-
modulating protein; IRL, inverted repeat left; IRR, inverted repeat right; IS, insertion sequence; mcr-8.1, mobilized colistin resistance; NAT,
N-acetyltransferase; Sul2, dihydropteroate synthase.
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copy of the IncFIB(pQil) plasmid with an identical resistance profile was recovered from
each MCRPKP isolate and shared 99.72% nucleotide identity at 70% coverage with
previously described plasmids (accession no. CP023922.1 and CP024040.1). However,
those plasmids (CP023922.1 and CP024040.1) were absent frommcr-like genes (Fig. 2B).
The genetic environment around mcr-8.1 in IncFIB(pQil)-MCR-8.1 (pKP697, pKP782, and
pKP914) shares identity with a previously describedmcr-8.1-containing plasmid isolated
from pigs in China (accession no. MG736312.1), although the plasmids harboring
mcr-8.1 in this study are truncated at the 5= end and IS903B at the 3= end was replaced
by ISKpN14 (14) (Fig. 2C). It is possible that mcr-8.1 originally was transposed to the
IncFIB(pQil) plasmid by an IS903B composite transposon (Fig. 2B and C). An array of
AMR genes (blaTEM-1b and blaCTX-M-15) was in a composite transposon, flanked by
insertion sequences (Fig. 2B). Incidentally, all resistance components in IncFIB(pQil)
plasmids in this study were bracketed by IS903B from nucleotide position 20590 to
64656, demonstrating the potential for the transposition of the entire intervening DNA
segment. The conjugation assay confirmed the transferability of the plasmid containing
mcr-8.1 to E. coli J53 with a frequency range of 3.1# 10$2 to 8# 10$2. Phenotypically,
the transconjugants were resistant to ampicillin, amoxicillin-clavulanate, 3rd-generation
cephalosporins, trimethoprim-sulfamethoxazole, and colistin (Table S1).
The acquisition of a resistance plasmid may impose a fitness cost, depending on the
host and plasmid backbones (19, 20). We found a significantly lower growth rate over
time in TDM697b and TDM914b relative to that of E. coli J53 (P% 0.0001) (Fig. S4),
implying a significant fitness cost owing to the acquisition of a plasmid harboring
mcr-8.1. Compared to that of E. coli J53, a lower growth rate was also observed in
TDM782b; however, the fitness cost was not statistically significant (Fig. S4).
This is the first report of transferable colistin resistance associated with human
infections from Bangladesh. Given the acquisition of mcr-8.1 on a conjugative plasmid,
with good stability in ST15, a successful high-risk clone of K. pneumoniae, there is a
serious risk of dissemination of mcr-8.1 in South Asia.
Accession number(s). The nucleotide sequences of MCRPKP isolates are available
under NCBI accession no. CP046939 to CP046947, CP046381 to CP046385, and
CP046939 to CP046947.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
TEXT S1, DOCX file, 0.02 MB.
TEXT S2, DOCX file, 0.02 MB.
TEXT S3, DOCX file, 0.02 MB.
FIG S1, TIF file, 0.9 MB.
FIG S2, TIF file, 0.1 MB.
FIG S3, TIF file, 0.4 MB.
FIG S4, TIF file, 0.3 MB.
TABLE S1, DOCX file, 0.01 MB.
ACKNOWLEDGMENTS
Refath Farzana is the recipient of a Commonwealth Scholarship. We thank Ismail
Khan, Former Principal, Dhaka Medical College (DMC), for access to clinical data and
providing laboratory support in Dhaka.
We are grateful to S. M. Shamsuzzaman, Head, Department of Microbiology, DMC,
for permitting the use of BacT/Alert 3D (bioMérieux, North Carolina, USA) at the
Microbiology Department in DMC and to Owen B. Spiller for useful suggestions on
bioinformatic analysis.
REFERENCES
1. Martin RM, Bachman MA. 2018. Colonization, infection, and the acces-
sory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol 8:4.
https://doi.org/10.3389/fcimb.2018.00004.
2. Malchione MD, Torres LM, Hartley DM, Koch M, Goodman JL. 2019.
Carbapenem and colistin resistance in Enterobacteriaceae in Southeast
Asia: review and mapping of emerging and overlapping challenges. Int
Emergence of mcr-8.1 in Bangladesh
March/April 2020 Volume 5 Issue 2 e00023-20 msphere.asm.org 5






J Antimicrob Agents 54:381–399. https://doi.org/10.1016/j.ijantimicag
.2019.07.019.
3. Suwantarat N, Carroll KC. 2016. Epidemiology and molecular character-
ization of multidrug-resistant Gram-negative bacteria in Southeast Asia.
Antimicrob Resist Infect Control 5:5:15. https://doi.org/10.1186/s13756
-016-0115-6.
4. Davies M, Walsh TR. 2018. A colistin crisis in India. Lancet Infect Dis
18:256–257. https://doi.org/10.1016/S1473-3099(18)30072-0.
5. Ghafur A, Shankar C, GnanaSoundari P, Venkatesan M, Mani D,
Thirunarayanan MA, Veeraraghavan B. 2019. Detection of chromosomal
and plasmid-mediated mechanisms of colistin resistance in Escherichia
coli and Klebsiella pneumoniae from Indian food samples. J Glob Anti-
microb Resist 16:48–52. https://doi.org/10.1016/j.jgar.2018.09.005.
6. Lv J, Mohsin M, Lei S, Srinivas S, Wiqar RT, Lin J, Feng Y. 2018. Discovery
of a mcr-1-bearing plasmid in commensal colistin-resistant Escherichia
coli from healthy broilers in Faisalabad, Pakistan. Virulence 9:994–999.
https://doi.org/10.1080/21505594.2018.1462060.
7. Islam A, Rahman Z, Monira S, Rahman MA, Camilli A, George CM, Ahmed
N, Alam M. 2017. Colistin resistant Escherichia coli carrying mcr-1 in
urban sludge samples: Dhaka, Bangladesh. Gut Pathog 9:77. https://doi
.org/10.1186/s13099-017-0227-4.
8. Sobur A, Haque ZF, Sabuj AA, Ievy S, Rahman AT, El Zowalaty ME,
Rahman T. 2019. Molecular detection of multidrug and colistin-resistant
Escherichia coli isolated from house flies in various environmental set-
tings. Future Microbiol 14:847–858. https://doi.org/10.2217/fmb-2019
-0053.
9. Farzana R, Jones LS, Rahman MA, Toleman MA, Sands K, Portal E,
Boostrom I, Kalam MA, Hassan B, Uddin AN, Walsh TR. 2019. Emergence
of mcr-1 mediated colistin resistant Escherichia coli from a hospitalized
patient in Bangladesh. J Infect Dev Ctries 13:773–776. https://doi.org/10
.3855/jidc.11541.
10. Timofte D, Dan M, Maciuca IE, Ciucu L, Dabija ER, Guguianu E, Panzaru
CV. 2015. Emergence of concurrent infections with colistin-resistant
ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acineto-
bacter baumannii sensitive to colistin only in a Romanian cardiac inten-
sive care unit. Eur J Clin Microbiol Infect Dis 34:2069–2074. https://doi
.org/10.1007/s10096-015-2453-3.
11. Olaitan AO, Morand S, Rolain JM. 2014. Mechanisms of polymyxin
resistance: acquired and intrinsic resistance in bacteria. Front Microbiol
5:643. https://doi.org/10.3389/fmicb.2014.00643.
12. Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, Doi Y, Tian G, Dong
B, Huang X, Yu L-F, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu
J-H, Shen J. 2016. Emergence of plasmid-mediated colistin resistance
mechanism MCR-1 in animals and human beings in China: a microbio-
logical and molecular biological study. Lancet Infect Dis 16:161–168.
https://doi.org/10.1016/S1473-3099(15)00424-7.
13. Wang Y, Tian G-B, Zhang R, Shen Y, Tyrrell JM, Huang X, Zhou H, Lei L,
Li H-Y, Doi Y, Fang Y, Ren H, Zhong L-L, Shen Z, Zeng K-J, Wang S, Liu
J-H, Wu C, Walsh TR, Shen J. 2017. Prevalence, risk factors, outcomes, and
molecular epidemiology of mcr-1-positive Enterobacteriaceae in pa-
tients and healthy adults from China: an epidemiological and clinical
study. Lancet Infect Dis 17:390–399. https://doi.org/10.1016/S1473
-3099(16)30527-8.
14. Wang X, Wang Y, Zhou Y, Li J, Yin W, Wang S, Zhang S, Shen J, Shen Z,
Wang Y. 2018. Emergence of a novel mobile colistin resistance gene,
mcr-8, in NDM-producing Klebsiella pneumoniae. Emerg Microbes Infect
7:122. https://doi.org/10.1038/s41426-018-0124-z.
15. Harada K, Shimizu T, Mukai Y, Kuwajima K, Sato T, Usui M, Tamura Y, Kimura
Y, Miyamoto T, Tsuyuki Y, Ohki A, Kataoka Y. 2016. Phenotypic and molec-
ular characterization of antimicrobial resistance in Klebsiella spp. isolates
from companion animals in Japan: clonal dissemination of multidrug-
resistant extended-spectrum !-lactamase-producing Klebsiella pneu-
moniae. Front Microbiol 7:1021. https://doi.org/10.3389/fmicb.2016.01021.
16. Yang Q, Li M, Spiller OB, Andrey DO, Hinchliffe P, Li H, MacLean C,
Niumsup P, Powell L, Pritchard M, Papkou A, Shen Y, Portal E, Sands K,
Spencer J, Tansawai U, Thomas D, Wang S, Wang Y, Shen J, Walsh T.
2017. Balancing mcr-1 expression and bacterial survival is a delicate
equilibrium between essential cellular defence mechanisms. Nat Com-
mun 8:2054. https://doi.org/10.1038/s41467-017-02149-0.
17. Stalder T, Rogers LM, Renfrow C, Yano H, Smith Z, Top EM. 2017.
Emerging patterns of plasmid-host coevolution that stabilize antibiotic
resistance. Sci Rep 7:4853. https://doi.org/10.1038/s41598-017-04662-0.
18. Farzana R, Jones LS, Rahman MA, Andrey DO, Sands K, Portal E, Watkins
WJ, Pervin M, Banerjee M, Walsh TR. 2019. Outbreak of hypervirulent
multidrug-resistant Klebsiella variicola causing high mortality in neo-
nates in Bangladesh. Clin Infect Dis 68:1225–1227. https://doi.org/10
.1093/cid/ciy778.
19. Bouma JE, Lenski RE. 1988. Evolution of a bacteria/plasmid association.
Nature 335:351–352. https://doi.org/10.1038/335351a0.
20. Humphrey B, Thomson NR, Thomas CM, Brooks K, Sanders M, Delsol AA,
Roe JM, Bennett PM, Enne VI. 2012. Fitness of Escherichia coli strains
carrying expressed and partially silent IncN and IncP1 plasmids. BMC
Microbiol 12:53. https://doi.org/10.1186/1471-2180-12-53.
Farzana et al.
March/April 2020 Volume 5 Issue 2 e00023-20 msphere.asm.org 6
 on April 1, 2020 by guest
http://m
sphere.asm
.org/
Downloaded from
 
